Please login to the form below

Not currently logged in
Email:
Password:

injectables

This page shows the latest injectables news and features for those working in and with pharma, biotech and healthcare.

Celgene files luspatercept ahead of key merger vote

Celgene files luspatercept ahead of key merger vote

Analysts believe the subcutaneous injectable drug could hit peak sales of about $2bn, with MDS accounting for two-thirds or more of these revenues.

Latest news

More from news
Approximately 3 fully matching, plus 365 partially matching documents found.

Latest Intelligence

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    CAM2038 is an injectable solution that slowly releases buprenorphine – the most common drug used to treat opioid addiction – into the body, eliminating the need for daily dosages as well as the ... Risankizumab is almost inevitably going to have a

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    consequence. Take special measures to ensure adherence to the investigation product for non- injectable therapies.This is mandatory for all long-lasting prophylactic treatments.

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    The issues that need urgent discussion are sectors with 100% generic penetration, such as hospital injectables and oncology products where there is no growth, yet companies have to contend with rising

  • Deal Watch - May 2017 Deal Watch - May 2017

    is making two acquisitions worth over $5.5bn.  The acquisition of Akorn, a US based company that manufactures “alternate” formulations such as liquids, gels and injectables  and markets a range of ... strengthen Kabi’s already strong position

  • Deal Watch March 2017 Deal Watch March 2017

    Sihuan Pharmaceuticals, a leader in China’s cardio-cerebrovascular area, has acquired the manufacturer Ambest Pharmaceuticals, with its portfolio of injectable products, for $160m. ... 190. Ambest Pharmaceutical. Sihuan Pharmaceutical. Acquisition.

More from intelligence
Approximately 0 fully matching, plus 29 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics